200 related articles for article (PubMed ID: 8568137)
21. Comparison of 3 different doses of budesonide and placebo on the early asthmatic response to inhaled allergen.
Swystun VA; Bhagat R; Kalra S; Jennings B; Cockcroft DW
J Allergy Clin Immunol; 1998 Sep; 102(3):363-7. PubMed ID: 9768574
[TBL] [Abstract][Full Text] [Related]
22. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma.
Becker AB; Simons FE
J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):891-5. PubMed ID: 2574732
[TBL] [Abstract][Full Text] [Related]
23. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma.
Simons FE; Soni NR; Watson WT; Becker AB
J Allergy Clin Immunol; 1992 Nov; 90(5):840-6. PubMed ID: 1358932
[TBL] [Abstract][Full Text] [Related]
24. Formoterol, a new long-acting selective beta 2-agonist, decreases airway responsiveness in children with asthma.
Becker AB; Simons FE
Lung; 1990; 168 Suppl():99-102. PubMed ID: 1974689
[TBL] [Abstract][Full Text] [Related]
25. Low-dose salbutamol suppresses airway responsiveness to histamine but not methacholine in subjects with asthma.
Matsumoto K; Aizawa H; Fukuyama S; Yoshida M; Komori M; Takata S; Koto H; Inoue H
Respir Investig; 2013 Sep; 51(3):158-65. PubMed ID: 23978642
[TBL] [Abstract][Full Text] [Related]
26. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
Giannini D; Di Franco A; Bacci E; Dente FL; Taccola M; Vagaggini B; Paggiaro P
Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
[TBL] [Abstract][Full Text] [Related]
27. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects.
Gauvreau GM; Jordana M; Watson RM; Cockroft DW; O'Byrne PM
Am J Respir Crit Care Med; 1997 Dec; 156(6):1738-45. PubMed ID: 9412549
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of single-dose inhaled corticosteroid activity with an allergen challenge model.
Kidney JC; Boulet LP; Hargreave FE; Deschesnes F; Swystun VA; O'Byrne PM; Choudry N; Morris MM; Jennings B; Andersson N; Andreasson A; Cockcroft DW
J Allergy Clin Immunol; 1997 Jul; 100(1):65-70. PubMed ID: 9257789
[TBL] [Abstract][Full Text] [Related]
29. Contrasting effects of allergen challenge on airway responsiveness to cysteinyl leukotriene D(4) and methacholine in mild asthma.
Ketchell RI; D'Amato M; Jensen MW; O'Connor BJ
Thorax; 2002 Jul; 57(7):575-80. PubMed ID: 12096198
[TBL] [Abstract][Full Text] [Related]
30. Reduced dose salbutamol in comparison with standard dosage for symptom relief in asthma.
Yates DH; Peters MJ; Keatings V; Thomas PS; Barnes PJ
Eur Respir J; 1995 Nov; 8(11):1847-51. PubMed ID: 8620950
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
Parameswaran K; Inman MD; Watson RM; Morris MM; Efthimiadis A; Ventresca PG; Lam R; O'Byrne PM; Hargreave FE
Can Respir J; 2000; 7(4):313-9. PubMed ID: 10980457
[TBL] [Abstract][Full Text] [Related]
32. Effect of an inhaled glucocorticosteroid on mast cell and smooth muscle beta 2 adrenergic tolerance in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Thorax; 1998 Feb; 53(2):110-3. PubMed ID: 9624295
[TBL] [Abstract][Full Text] [Related]
33. Tolerance to beta-agonists during acute bronchoconstriction.
Hancox RJ; Aldridge RE; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Town GI; Taylor DR
Eur Respir J; 1999 Aug; 14(2):283-7. PubMed ID: 10515402
[TBL] [Abstract][Full Text] [Related]
34. A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction.
van Noord JA; Smeets JJ; Maesen FP
Respir Med; 1998 Dec; 92(12):1346-51. PubMed ID: 10197228
[TBL] [Abstract][Full Text] [Related]
35. The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.
Bel EH; Zwinderman AH; Timmers MC; Dijkman JH; Sterk PJ
Thorax; 1991 Jan; 46(1):9-14. PubMed ID: 1871705
[TBL] [Abstract][Full Text] [Related]
36. Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma.
O'Byrne PM; van der Linde J; Cockcroft DW; Gauvreau GM; Brannan JD; Fitzgerald M; Watson RM; Milot J; Davis B; O'Connor M; Hart L; Korducki L; Hamilton AL; Boulet LP
J Allergy Clin Immunol; 2009 Dec; 124(6):1217-21. PubMed ID: 20004781
[TBL] [Abstract][Full Text] [Related]
37. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
[TBL] [Abstract][Full Text] [Related]
38. Rapid onset of tolerance to beta-agonist bronchodilation.
Haney S; Hancox RJ
Respir Med; 2005 May; 99(5):566-71. PubMed ID: 15823453
[TBL] [Abstract][Full Text] [Related]
39. [Duration of the effect of inhaled corticosteroids on lung function and sensitivity of the respiratory tract in patients with bronchial asthma].
Magnussen H; Willenbrock U; Jörres R
Med Klin (Munich); 1995 Apr; 90(4):214-9. PubMed ID: 7776933
[TBL] [Abstract][Full Text] [Related]
40. Proof-of-concept evaluation of trough airway hyper-responsiveness following regular racemic or levosalbutamol in genotype-stratified steroid-treated persistent asthmatic patients.
Anderson WJ; Short PM; Williamson PA; Morrison AE; Palmer C; Tavendale R; Lipworth BJ
Clin Sci (Lond); 2014 Jan; 126(1):75-83. PubMed ID: 23829494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
